Mineralys Therapeutics, Inc. (MLYS) Institutional Ownership & Insider Trading
226 institutions reported holding Mineralys Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 87 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MLYSMineralys Therapeutics, Inc.Follow MLYS — free
—
Price chart with a free account
- Market cap
- 1.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters226 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +9.4%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 226 | 100 | +9.4% | 88 | 30 | 59 | 20 |
| Mar 26 | 213 | 91 | +2.6% | 90 | 20 | 47 | 35 |
| Dec 25 | 222 | 88 | +9.1% | 80 | 42 | 70 | 18 |
| Sep 25 | 189 | 79 | +21.6% | 63 | 39 | 60 | 14 |
| Jun 25 | 164 | 66 | +7.1% | 73 | 40 | 29 | 21 |
| Mar 25 | 148 | 61 | +30.2% | 49 | 50 | 24 | 13 |
| Dec 24 | 107 | 46 | +4.5% | 38 | 12 | 15 | 12 |
| Sep 24 | 106 | 44 | -1.4% | 35 | 14 | 20 | 6 |
Mineralys Therapeutics, Inc. — questions
- Who owns Mineralys Therapeutics, Inc. stock?
- 226 institutions reported Mineralys Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Catalys Pacific, LLC (8.9%), RA CAPITAL MANAGEMENT, L.P. (8.7%), BlackRock, Inc. (6.7%).
- Are Mineralys Therapeutics, Inc. insiders buying or selling?
- 87 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Mineralys Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.